Abstract
The p53 tumor suppressor gene is a sequence-specific transcription factor that activates the expression of genes engaged in promoting growth arrest or cell death in response to multiple forms of cellular stress. p53 expression is elevated in damaged neurons in acute models of injury such as ischemia and epilepsy and in brain tissue samples derived from animal models and patients with chronic neurodegenerative diseases. p53 deficiency or p53 inhibition protects neurons from a wide variety of acute toxic insults. Signal transduction pathways associated with p53-induced neuronal cell death are being characterized, suggesting that intervention may prove effective in maintaining neuronal viability and restoring function following neural injury and disease.
Similar content being viewed by others
REFERENCES
Ko, L. J. and Prives, C. 1996. p53: Puzzle and paradigm. Genes Dev. 10:1054–1072.
Giaccia, A. J. and Kastan, M. B. 1998. The complexity of p53 modulation: Emerging patterns from divergent signals. Genes Dev. 12:2973–2983.
Bates, S. and Vousden, K. H. 1996. p53 in signaling checkpoint arrest or apoptosis. Curr. Opin. Genet. Dev. 6:12–18.
Asker, C., Wiman, K. G., and Selivanova, G. 1999. p53-induced apoptosis as a safeguard against cancer. Biochem. Biophys. Res. Commun. 265:1–6.
Miyashita, T., Harigai, M., Hanada, M., and Reed, J. C. 1994. Identification of a p53-dependent negative response element in the bcl-2 gene. Cancer Res. 54:3131–3135.
Roperch, J. P., Alvaro, V., Prieur, S., Tuynder, M., Nemani, M., Lethrosne, F., Piouffre, L., Gendron, M. C., Israeli, D., Dausset, J., Oren, M., Amson, R., and Telerman, A. 1998. Inhibition of presenilin 1 expression is promoted by p53 and p21WAF-1 and results in apoptosis and tumor suppression. Nat. Med. 4:835–838.
Ding, H. F., McGill, G., Rowan, S., Schmaltz, C., Shimamura, A., and Fisher, D. E. 1998. Oncogene-dependent regulation of caspase activation by p53 protein in a cell-free system. J. Biol. Chem. 273:28378–28383.
Gottlieb, E. and Oren, M. 1998. p53 facilitates pRb cleavage in IL-3 deprived cells: Novel pro-apoptotic activity of p53. EMBO J. 17:3587–3596.
Sakhi, S., Bruce, A., Sun, N., Tocco, G., Baudry, M., and Schreiber, S. S. 1994. p53 induction is associated with neuronal damage in the central nervous system. Proc. Natl. Acad. Sci. U.S.A. 91:7525–7529.
Sakhi, S., Sun, N., Wing, L. L., Mehta, P., and Schreiber, S. S. 1996. Nuclear accumulation of p53 protein following kainic acid-induced seizures. Neuroreport. 7:493–496.
Tan, Z., Sankar, R., Shin, D., Sun, N., Liu, H., Wasterlain, C. G., and Schreiber, S. S. 2002. Differential induction of p53 in immature and adult rat brain following lithium-pilocarpine status epilepticus. Brain Res. 928:187–193.
Qin, Z. H., Chen, R. W., Wang, Y., Nakai, M., Chuang, D. M., and Chase, T. N. 1999. Nuclear factor kappaB nuclear translocation upregulates c-Myc and p53 expression during NMDA receptor-mediated apoptosis in rat striatum. J. Neurosci. 19:4023–4033.
Wang, Y., Qin, Z. H., Nakai, M., Chen, R. W., Chuang, D. M., and Chase, T. N. 1999. Co-stimulation of cyclic-AMP-linked metabotropic glutamate receptors in rat striatum attenuates excitotoxin-induced nuclear factor-kappaB activation and apoptosis. NeuroScience. 94:1153–1162.
Nakai, M., Qin, Z. H., Chen, J. F., Wang, Y., and Chase, T. N. 2000. Kainic acid-induced apoptosis in rat striatum is associated with nuclear factor-kappaB activation. J. Neurochem. 74:647–658.
Napieralski, J. A., Raghupathi, R., and McIntosh, T. K. 1999. The tumor-suppressor gene, p53, is induced in injured brain regions following experimental traumatic brain injury. Brain Res. Mol. Brain Res. 71:78–86.
Muir, J. K., Raghupathi, R., Emery, D. L., Bareyre, F. M., and McIntosh, T. K. 1999. Postinjury magnesium treatment attenuates traumatic brain injury-induced cortical induction of p53 mRNA in rats. Exp. Neurol. 159:584–593.
Chopp, M., Li, Y., Zhang, Z. G., and Freytag, S. O. 1992. p53 expression in brain after middle cerebral artery occlusion in the rat. Biochem Biophys Res Commun. 182:1201–1207.
Watanabe, H., Ohta, S., Kumon, Y., Sakaki, S., and Sakanaka, M. 1999. Increase in p53 protein expression following cortical infarction in the spontaneously hypertensive rat. Brain Res. 837:38–45.
Citron, M., Oltersdorf, T., Haass, C., McConlogue, L., Hung, A. Y., Seubert, P., Vigo-Pelfrey, C., Lieberburg, I., and Selkoe, D. J. 1992. Mutation of the beta-amyloid precursor protein in familial Alzheimer's disease increases beta-protein production. Nature. 360:672–674.
Shoji, M., Golde, T. E., Ghiso, J., Cheung, T. T., Estus, S., Shaffer, L. M., Cai, X. D., McKay, D. M., Tintner, R., Frangione, B., and et al. 1992. Production of the Alzheimer amyloid beta protein by normal proteolytic processing. Science. 258:126–1299.
Busciglio, J., Gabuzda, D. H., Matsudaira, P., and Yankner, B. A. 1993. Generation of beta-amyloid in the secretory pathway in neuronal and nonneuronal cells. Proc. Natl. Acad. Sci. U.S.A. 90:2092–2096.
de la Monte, S. M., Sohn, Y. K., and Wands, J. R. 1997. Correlates of p53-and Fas (CD95)-mediated apoptosis in Alzheimer's disease. J. Neurol. Sci. 152:73–83.
de la Monte, S. M., Sohn, Y. K., Ganju, N., and Wands, J. R. 1998. P53-and CD95-associated apoptosis in neurodegenerative diseases. Lab. Invest. 78:401–411.
LaFerla, F. M., Hall, C. K., Ngo, L., and Jay, G. 1996. Extra-cellular deposition of beta-amyloid upon p53-dependent neuronal cell death in transgenic mice. J. Clin. Invest. 98:1626–1632.
Jiang, Y. H., Armstrong, D., Albrecht, U., Atkins, C. M., Noebels, J. L., Eichele, G., Sweatt, J. D., and Beaudet, A. L. 1998. Mutation of the Angelman ubiquitin ligase in mice causes increased cytoplasmic p53 and deficits of contextual learning and long-term potentiation. Neuron. 21:799–811.
Sawa, A. 1999. Neuronal cell death in Down's syndrome. J. Neural Transm. Suppl. 57:87–97.
Seidl, R., Fang-Kircher, S., Bidmon, B., Cairns, N., and Lubec, G. 1999. Apoptosis-associated proteins p53 and APO-1/Fas (CD95) in brains of adult patients with Down syndrome. Neurosci. Lett. 260:9–12.
Martin, L. J. 2000. p53 is abnormally elevated and active in the CNS of patients with amyotrophic lateral sclerosis. Neurobiol. Dis. 7:613–622.
Steffan, J. S., Kazantsev, A., Spasic-Boskovic, O., Greenwald, M., Zhu, Y. Z., Gohler, H., Wanker, E. E., Bates, G. P., Housman, D. E., and Thompson, L. M. 2000. The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription. Proc. Natl. Acad. Sci. U.S.A. 97:6763–6768.
Uberti, D., Belloni, M., Grilli, M., Spano, P., and Memo, M. 1998. Induction of tumour-suppressor phosphoprotein p53 in the apoptosis of cultured rat cerebellar neurones triggered by excitatory amino acids. Eur. J. Neurosci. 10:246–254.
Chen, R. W. and Chuang, D. M. 1999. Long term lithium treatment suppresses p53 and Bax expression but increases Bcl-2 expression: A prominent role in neuroprotection against exitotoxicity. J. Biol. Chem. 274:6039–6042.
Anderson, C. N. G. and Tolkovsky, A. M. 1999. A role for MAPK/ERK in sympathetic neuron survival: Protection against a p53-dependent, JNK-independent induction of apoptosis by cytosine arabinoside. J. Neurosci. 19:664–673.
Chen, R. W., Saunders, P. A., Wei, H., Li, Z., Seth, P., and Chuang, D. M. 1999. Involvement of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and p53 in neuronal apoptosis: Evidence that GAPDH is upregulated by p53. J. Neurosci. 19:9654–9662.
Jordan, J., Galindo, M. F., Prehn, J. H., Weichselbaum, R. R., Beckett, M., Ghadge, G. D., Roos, R. P., Leiden, J. M., and Miller, R. J. 1997. p53 expression induces apoptosis in hippo-campal pyramidal neuron cultures. J. Neurosci. 17:1397–1405.
Morris, E. J., Keramaris, E., Rideout, H. J., Slack, R. S., Dyson, N. J., Stefanis, L., and Park, D. S. 2001. Cyclin-dependent kinases and p53 pathways are activated independently and mediate Bax activation in neurons after DNA damage. J. Neurosci. 21:5017–5026.
Frank, K. M., Sharpless, N. E., Gao, Y., Sekiguchi, J. M., Ferguson, D. O., Zhu, C., Manis, J. P., Horner, J., DePinho, R. A., and Alt, F. W. 2000. DNA ligase IV deficiency in mice leads to defective neurogenesis and embryonic lethality via the p53 pathway. Mol. Cell. 5:993–1002.
Banasiak, K. J. and Haddad, G. G. 1998. Hypoxia-induced apoptosis: Effect of hypoxic severity and role of p53 in neuronal cell death. Brain Res. 797:295–304.
Aloyz, R. S., Bamji, S. X., Pozniak, C. D., Toma, J. G., Atwal, J., Kaplan, D. R., and Miller, F. D. 1998. p53 is essential for developmental neuron death as regulated by the TrkA and p75 neurotrophin receptors. J. Cell Biol. 143:1691–1703.
Crumrine, R. C., Thomas, A. L., and Morgan, P. F. 1994. Attenuation of p53 expression protects against focal ischemic damage in transgenic mice. J. Cereb. Blood Flow Metab. 14:887–891.
Johnson, M. D., Xiang, H., London, S., Kinoshita, Y. Knudson, M. Mayberg, M., Korsmeyer, S. J., and Morrison, R. S. 1998. Evidence for involvement of Bax and p53, but not caspases, in radiation-induced cell death of cultured postnatal hippocampal neurons. J. Neurosci. Res. 54:721–733.
Wood, K. A. and Youle, R. J. 1995. The role of free radicals and p53 in neuron apoptosis in vivo. J. Neurosci. 15:5851–5857.
Enokido, Y., Araki, T., Tanaka, K., Aizawa, S., and Hatanaka, H. 1996. Involvement of p53 in DNA strand break-induced apoptosis in postmitotic CNS neurons. Eur. J. Neurosci. 8: 1812–1821.
Herzog, K. H., Chong, M. J., Kapsetaki, M., Morgan, J. I., and McKinnon, P. J. 1998. Requirement for Atm in ionizing radiation-induced cell death in the developing central nervous system. Science. 280:1089–1091.
D'sa-Eipper, C., Leonard, J. R., Putcha, G., Zheng, T. S., Flavell, R. A., Rakic, P., Kuida, K., and Roth, K. A. 2001. DNA damage-induced neural precursor cell apoptosis requires p53 and caspase 9 but neither Bax nor caspase 3. Development. 128:137–146.
Morrison, R. S., Wenzel, H. J., Kinoshita, Y., Robbins, C. A., Donehower, L. A., and Schwartzkroin, P. A. 1996. Loss of the p53 tumor suppressor gene protects neurons from kainate-induced cell death. J. Neurosci. 16:1337–1345.
Trimmer, P. A., Smith, T. S., Jung, A. B., and Bennett, J. P., Jr. 1996. Dopamine neurons from transgenic mice with a knockout of the p53 gene resist MPTP neurotoxicity. Neurodegeneration. 5:233–239.
Hirata, H. and Cadet, J. L. 1997. p53-knockout mice are protected against the long-term effects of methamphetamine on dopaminergic terminals and cell bodies. J. Neurochem. 69:780–790.
Sakhi, S., Gilmore, W., Tran, N. D., and Schreiber, S. S. 1996. p53-deficient mice are protected against adrenalectomy-induced apoptosis. Neuroreport. 8:233–235.
Martin, L. J., Kaiser, A., Yu, J. W., Natale, J. E., and Al-Abdulla, N. A. 2001. Injury-induced apoptosis of neurons in adult brain is mediated by p53-dependent and p53-independent pathways and requires Bax. J. Comp. Neurol. 433:299–311.
Enokido, Y., Araki, T., Aizawa, S., and Hatanaka, H. 1996. p53 involves cytosine arabinoside-induced apoptosis in cultured cerebellar granule neurons. Neurosci. Lett. 203:1–4.
Araki, T., Enokido, Y., Inamura, N., Aizawa, S., Reed, J. C., and Hatanaka, H. 1998. Changes in c-Jun but not Bcl-2 family proteins in p53-dependent apoptosis of mouse cerebellar granule neurons induced by DNA damaging agent bleomycin. Brain Res. 794:239–247.
Xiang, H., Kinoshita, Y., Knudson, C. M., Korsmeyer, S. J., Schwartzkroin, P. A., and Morrison, R. S. 1998. Bax involvement in p53-mediated neuronal cell death. J. Neurosci. 18:1363–1373.
Zaidi, A. U., D'sa-Eipper, C., Brenner, J., Kuida, K., Zheng, T. S., Flavell, R. A., Rakic, P., and Roth, K. A. 2001. Bcl-X(L)-caspase-9 interactions in the developing nervous system: Evidence for multiple death pathways. J. Neurosci. 21:169–175.
Halterman, M. W., Miller, C. C., and Federoff, H. J. 1999. Hypoxia-inducible factor-1 alpha mediates hypoxia-induced delayed neuronal death that involves p53. J. Neurosci. 19:6818–6824.
Vogel, K. S. and Parada, L. F. 1998. Sympathetic neuron survival and proliferation are prolonged by loss of p53 and neurofibromin. Mol. Cell Neurosci. 11:19–28.
Lee, E. Y., Chang, C. Y., Hu, N., Wang, Y. C., Lai, C. C., Herrup, K., Lee, W. H., and Bradley, A. 1992. Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis. Nature. 359:288–294.
Macleod, K. F., Hu, Y., and Jacks, T. 1996. Loss of Rb activates both p53-dependent and independent cell death pathways in the developing mouse nervous system. EMBO. J. 15:6178–6188.
Yeung, M. C., Geertsma, F., Liu, J., and Lau, A. S. 1998. Inhibition of HIV-1 gp120-induced apoptosis in neuroblastoma SK-N-SH cells by an antisense oligodeoxynucleotide against p53. AIDS 12:349–354.
Lakkaraju, A., Dubinsky, J. M., Low, W. C., and Rahman, Y. E. 2001. Neurons are protected from excitotoxic death by p53 antisense oligonucleotides delivered in anionic liposomes. J. Biol. Chem. 276:32000–32007.
Culmsee, C., Zhu, X., Yu, Q. S., Chan, S. L., Camandola, S., Guo, Z., Greig, N. H., and Mattson, M. P. 2001. A synthetic inhibitor of p53 protects neurons against death induced by ischemic and excitotoxic insults, and amyloid beta-peptide. J Neurochem. 77:220–228.
Zhang, Y., McLaughlin, R., Goodyer, C., and LeBlanc, A. 2002. Selective cytotoxicity of intracellular amyloid ta peptide 1-42 through p53 and Bax in cultured primary human neurons. J. Cell Biol. 156:519–529.
Shahbazian, M. D., Orr, H. T., and Zoghbi, H. Y. 2001. Reduction of purkinje cell pathology in SCA1 transgenic mice by p53 deletion. Neurobiol. Dis. 8:974–981.
Johnson, M. D., Kinoshita, Y., Xiang, H., Ghatan, S., and Morrison, R. S. 1999. Contribution of p53-dependent caspase activation to neuronal cell death declines with neuronal maturation. J. Neurosci. 19:2996–3006.
Fortin, A., Cregan, S. P., MacLaurin, J. G., Kushwaha, N., Hickman, E. S., Thompson, C. S., Hakim, A., Albert, P. R., Cecconi, F., Helin, K., Park, D. S., and Slack, R. S. 2001. APAF1 is a key transcriptional target for p53 in the regulation of neuronal cell death. J. Cell Biol. 155:207–2016.
Mattson, M. P., Gary, D. S., Chan, S. L., and Duan, W. 2001. Perturbed endoplasmic reticulum function, synaptic apoptosis and the pathogenesis of Alzheimer's disease. Biochem. Soc. Symp. 67:151–162.
Kuntz, C. T., Kinoshita, Y., Beal, M. F., Donehower, L. A., and Morrison, R. S. 2000. Absence of p53: No effect in a transgenic mouse model of familial amyotrophic lateral sclerosis. Exp. Neurol. 165:184–190.
Prudlo, J., Koenig, J., Graser, J., Burckhardt, E., Mestres, P., Menger, M., and Roemer, K. 2000. Motor neuron cell death in a mouse model of FALS is not mediated by the p53 cell survival regulator. Brain Res. 879:183–187.
Jayaraman, J. and Prives, C. 1995. Activation of p53 sequence-specific DNA binding by short single strands of DNA requires the p53 C-terminus. Cell. 81:1021–1029.
Huang, L. C., Clarkin, K. C., and Wahl, G. M. 1996. Sensitivity and selectivity of the DNA damage sensor responsible for activating p53-dependent G1 arrest. Proc. Natl. Acad. Sci. U.S.A. 93:4827–4832.
Chong, M. J., Murray, M. R., Gosink, E. C., Russell, H. R., Srinivasan, A., Kapsetaki, M., Korsmeyer, S. J., and McKinnon, P. J. 2000. Atm and Bax cooperate in ionizing radiation-induced apoptosis in the central nervous system. Proc. Natl. Acad. Sci. U.S.A. 97:889–894.
Liu, Z. G., Baskaran, R., Lea-Chou, E. T., Wood, L. D., Chen, Y., Karin, M., and Wang, J. Y. 1996. Three distinct signalling responses by murine fibroblasts to genotoxic stress. Nature. 384:273–276.
Gibson, S., Widmann, C., and Johnson, G. L. 1999. Differential involvement of MEK kinase 1 (MEKK1) in the induction of apoptosis in response to microtubule-targeted drugs versus DNA damaging agents. J Biol Chem. 274:10916–10922.
Fuchs, S. Y., Adler, V., Pincus, M. R., and Ronai, Z. 1998. MEKK1/JNK signaling stabilizes and activates p53. Proc. Natl. Acad. Sci U.S.A. 95:10541–10546.
Bulavin, D. V., Saito, S., Hollander, M. C., Sakaguchi, K., Anderson, C. W., Appella, E., and Fornace, A. J., Jr. 1999. Phosphorylation of human p53 by p38 kinase coordinates N-terminal phosphorylation and apoptosis in response to UV radiation. EMBO. J. 18:6845–6854.
She, Q. B., Chen, N., and Dong, Z. 2000. ERKs and p38 kinase phosphorylate p53 protein at serine 15 in response to UV radiation. J. Biol. Chem. 275:20444–20449.
Xia, Z., Dickens, M., Raingeaud, J., Davis, R. J., and Green-berg, M. E. 1995. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science. 270:1326–1331.
Dudek, H., Datta, S. R., Franke, T. F., Birnbaum, M. J., Yao, R., Cooper, G. M., Segal, R. A., Kaplan, D. R., and Greenberg, M. E. 1997. Regulation of neuronal survival by the serine-thre-onine protein kinase Akt. Science. 275:661–665.
Philpott, K. L., McCarthy, M. J.,Klippel, A., and Rubin, L. L. 1997. Activated phosphatidylinositol 3-kinase and Akt kinase promote survival of superior cervical neurons. J. Cell Biol. 139:809–815.
Datta, S. R., Dudek, H., Tao, X., Masters, S., Fu, H., Gotoh, Y., and Greenberg, M. E. 1997. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell. 91:231–241.
Zha, J., Harada, H., Yang, E., Jockel, J., and Korsmeyer, S. J. 1996. Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L). Cell. 87:619–628.
Yamaguchi, A., Tamatani, M., Matsuzaki, H., Namikawa, K., Kiyama, H., Vitek, M. P., Mitsuda, N., and Tohyama, M. 2001. Akt activation protects hippocampal neurons from apoptosis by inhibiting transcriptional activity of p53. J. Biol. Chem. 276: 5256–5264.
Mazzoni, I. E., Said, F. A., Aloyz, R., Miller, F. D., and Kaplan, D. 1999. Ras regulates sympathetic neuron survival by suppressing the p53-mediated cell death pathway. J. Neurosci. 19:9716–9727.
Deckwerth, T. L., Elliott, J. L., Knudson, C. M., Johnson, E. M., Jr., Snider, W. D., and Korsmeyer, S. J. 1996. BAX is required for neuronal death after trophic factor deprivation and during development. Neuron. 17:401–411.
Liu, Y. and Kulesz-Martin M. 2001. p53 protein at the hub of cellular DNA damage response pathways through sequence-specific and non-sequence-specific DNA binding. Carcinogenesis. 22:851–860.
Oda, K., Arakawa, H., Tanaka, T., Matsuda, K., Tanikawa, C., Mori, T., Nishimori, H., Tamai, K., Tokino, T., Nakamura, Y., and Taya, Y. 2000. p53AIP1, a potential mediator of p53-dependent apoptosis, and its regulation by Ser-46-phosphorylated p53. Cell. 102:849–862.
Daily, D., Barzilai, A., Offen, D., Kamsler, A., Melamed, E., and Ziv, I. 1999. The involvement of p53 in dopamine-induced apoptosis of cerebellar granule neurons and leukemic cells overexpressing p53. Cell Mol. Neurobiol. 19:261–276.
Lee, Y., Chong, M. J., and McKinnon, P. J. 2001. Ataxia telangiectasia mutated-dependent apoptosis after genotoxic stress in the developing nervous system is determined by cellular differentiation status. J. Neurosci. 21:6687–6693.
Liu, W., Rong, Y., Baudry, M., and Schreiber, S. S. 1999. Status epilepticus induces p53 sequence-specific DNA binding in mature rat brain. Brain Res. Mol. Brain Res. 63:248–253.
Kondo, M., Shibata, T., Kumagai, T., Osawa, T., Shibata, N., Kobayashi, M., Sasaki, S., Iwata, M., Noguchi, N., and Uchida, K. 2002. 15-Deoxy-delta 12,14-prostaglandin J2: The endogenous electrophile that induces neuronal apoptosis. Proc. Natl. Acad. Sci. U.S.A. 99:7367–7372.
Ryan, K. M., Ernst, M. K., Rice, N. R., and Vousden, K. H. 2000. Role of NF-kappaB in p53-mediated programmed cell death. Nature. 404:892–897.
Nonaka, S. and Chuang, D. M. 1998. Neuroprotective effects of chronic lithium on focal cerebral ischemia in rats. Neuroreport. 9:2081–2084.
Xu, X., Yang, D., Wyss-Coray, T., Yan, J., Gan, L., Sun, Y., and Mucke, L. 1999. Wild-type but not Alzheimer-mutant amyloid precursor protein confers resistance against p53-mediated apoptosis. Proc. Natl. Acad. Sci. U.S.A. 96:7547–7552.
Thornborrow, E. C., Patel, S., Mastropietro, A. E., Schwartzfarb, E. M., and Manfredi, J. J. 2002. A conserved intronic response element mediates direct p53-dependent transcriptional activation of both the human and murine bax genes. Oncogene. 21:990–999.
Buckbinder, L., Talbott, R., Velasco-Miguel, S., Takenaka, I., Faha, B., Seizinger, B. R., and Kley, N. 1995. Induction of the growth inhibitor IGF-binding protein 3 by p53. Nature. 377: 646–649.
Reinke, V. and Lozano, G. 1997. The p53 targets mdm2 and Fas are not required as mediators of apoptosis in vivo. Oncogene. 15:1527–1534.
Kobayashi, T., Ruan, S., Jabbur, J. R., Consoli, U., Clodi, K., Shiku, H., Owen-Schaub, L. B., Andreeff, M., Reed, J. C., and Zhang, W. 1998. Differential p53 phosphorylation and activation of apoptosis-promoting genes Bax and Fas/APO-1 by irradiation and ara-C treatment. Cell Death Differ. 5:584–591.
Polyak, K., Xia, Y., Zweier, J. L., Kinzler, K. W., and Vogelstein, B. 1997. A model for p53-induced apoptosis. Nature. 389:300–305.
Brodsky, M. H., Nordstrom, W., Tsang, G., Kwan, E., Rubin, G. M., and Abrams, J. M. 2000. Drosophila p53 binds a damage response element at the reaper locus. Cell. 101:103–113.
Prisco, M., Hongo, A., Rizzo, M. G., Sacchi, A., and Baserga, R. 1997. The insulin-like growth factor I receptor as a physiologically relevant target of p53 in apoptosis caused by interleukin-3 withdrawal. Mol. Cell Biol. 17:1084–1092.
Murphy, M., Hinman, A., and Levine, A. J. 1996. Wild-type p53 negatively regulates the expression of a microtubule-associated protein. Genes Dev. 10:2971–2980.
Li, P. F., Dietz, R., and von Harsdorf, R. 1999. p53 regulates mi-tochondrial membrane potential through reactive oxygen species and induces cytochrome c-independent apoptosis blocked by Bcl-2. EMBO. J. 18:6027–6036.
Deckwerth, T. L. and Johnson, E. M., Jr. 1993. Temporal analysis of events associated with programmed cell death (apoptosis) of sympathetic neurons deprived of nerve growth factor. J. Cell Biol. 123:1207–1222.
Vayssiere, J. L., Petit, P. X., Risler, Y., and Mignotte, B. 1994. Commitment to apoptosis is associated with changes in mito-chondrial biogenesis and activity in cell lines conditionally immortalized with simian virus 40. Proc. Natl. Acad. Sci. U.S.A. 91:11752–11756.
Zamzami, N., Marchetti, P., Castedo, M., Zanin, C., Vayssiere, J. L., Petit, P. X., and Kroemer, G. 1995. Reduction in mitochondrial potential constitutes an early irreversible step of programmed lymphocyte death in vivo. J. Exp. Med. 181:1661–1672.
Petit, P. X., Lecoeur, H., Zorn, E., Dauguet, C., Mignotte, B., and Gougeon, M. L. 1995. Alterations in mitochondrial structure and function are early events of dexamethasone-induced thymocyte apoptosis. J. Cell Biol. 130:157–167.
Marchetti, P., Castedo, M., Susin, S. A., Zamzami, N., Hirsch, T., Macho, A., Haeffner, A., Hirsch, F., Geuskens, M., and Kroemer, G. 1996. Mitochondrial permeability transition is a central coordinating event of apoptosis. J. Exp. Med. 184:1155–11560.
Xiang, J., Chao, D. T., and Korsmeyer, S. J. 1996. BAX-induced cell death may not require interleukin 1 beta-converting enzyme-like proteases. Proc. Natl. Acad. Sci. U.S.A 93: 14559–14563.
Cregan, S. P., MacLaurin, J. G., Craig, C. G., Robertson, G. S., Nicholson, D. W., Park, D. S., and Slack, R. S. 1999. Bax-dependent caspase-3 activation is a key determinant in p53-induced apoptosis in neurons. J. Neurosci. 19:7860–7869.
Ghatan, S., Larner, S., Kinoshita, Y., Hetman, M., Patel, L., Xia, Z., Youle, R. J., and Morrison, R. S. 2000. p38 MAP kinase mediates bax translocation in nitric oxide-induced apoptosis in neurons. J. Cell Biol. 150:335–347.
McGinnis, K. M., Gnegy, M. E., and Wang, K. K. 1999. Endogenous bax translocation in SH-SY5Y human neuroblastoma cells and cerebellar granule neurons undergoing apoptosis. J. Neurochem. 72:1899–1906.
Putcha, G. V., Deshmukh, M., and Johnson, E. M., Jr. 1999. BAX translocation is a critical event in neuronal apoptosis: Regulation by neuroprotectants, BCL-2, and caspases. J. Neurosci. 19:7476–7485.
Vekrellis, K., McCarthy, M. J., Watson, A., Whitfield, J., Rubin, L. L., and Ham, J. 1997. Bax promotes neuronal cell death and is downregulated during the development of the nervous system. Development. 124:1239–1249.
Martinou, I., Missotten, M., Fernandez, P. A., Sadoul, R., and Martinou, J. C. 1998. Bax and Bak proteins require caspase activity to trigger apoptosis in sympathetic neurons. Neuroreport. 9:15–19.
Marzo, I., Brenner, C., Zamzami, N., Jurgensmeier, J. M., Susin, S. A., Vieira, H. L., Prevost, M. C., Xie, Z., Matsuyama, S., Reed, J. C., and Kroemer, G. 1998. Bax and adenine nucleotide translocator cooperate in the mitochondrial control of apoptosis. Science. 281:2027–2031.
Schuler, M., Bossy-Wetzel, E., Goldstein, J. C., Fitzgerald, P., and Green, D. R. 2000. p53 induces apoptosis by caspase activation through mitochondrial cytochrome c release. J. Biol. Chem. 275:7337–7342.
Relaix, F., Wei, X., Li, W., Pan, J., Lin, Y., Bowtell, D. D., Sassoon, D. A., and Wu, X. 2000. Pw1/Peg3 is a potential cell death mediator and cooperates with Siah1a in p53-mediated apoptosis. Proc. Natl. Acad. Sci. U.S.A. 97:2105–2110.
Deng, Y. and Wu, X. 2000. Peg3/Pw1 promotes p53-mediated apoptosis by inducing Bax translocation from cytosol to mito-chondria. Proc. Natl. Acad. Sci. U.S.A 97:12050–12055.
Yamaguchi, A., Taniguchi, M., Hori, O., Ogawa, S., Tojo, N., Matsuoka, N., Miyake, S., Kasai, K., Sugimoto, H., Tamatani, M., Yamashita, T., and Tohyama, M. 2002. Peg3/Pw1 is involved in p53-mediated cell death pathway in brain ischemia/ hypoxia. J. Biol. Chem. 277:623–629.
Attardi, L. D., Reczek, E. E., Cosmas, C., Demicco, E. G., McCurrach, M. E., Lowe, S. W., and Jacks, T. 2000. PERP, an apoptosis-associated target of p53, is a novel member of the PMP-22/gas3 family. Genes Dev. 14:704–718.
Oda, E., Ohki, R., Murasawa, H., Nemoto, J., Shibue, T., Yamashita, T., Tokino, T., Taniguchi, T., and Tanaka, N. 2000. Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. Science. 288:1053–1058.
Ferri, K. F. and Kroemer, G. 2001. Organelle-specific initiation of cell death pathways. Nat. Cell Biol. 3:E255–E263.
Okamura, S., Arakawa, H., Tanaka, T., Nakanishi, H., Ng, C. C., Taya, Y., Monden, M., and Nakamura, Y. 2001. p53DINP1, a p53-inducible gene, regulates p53-dependent apoptosis. Mol. Cell. 8:85–94.
Levine, A. J. 1997. p53, the cellular gatekeeper for growth and division. Cell. 88:323–331.
Prives, C. and Hall, P. A. 1999. The p53 pathway. J. Pathol. 187:112–126.
Yu, J., Zhang, L., Hwang, P. M., Rago, C., Kinzler, K. W., and Vogelstein, B. 1999. Identification and classification of p53-regulated genes. Proc. Natl. Acad. Sci. U.S.A. 96:14517–14522.
Wang, L., Wu, Q., Qiu, P., Mirza, A., McGuirk, M., Kirschmeier, P., Greene, J. R., Wang, Y., Pickett, C. B., and Liu, S. 2001. Analyses of p53 target genes in the human genome by bioinfor-matic and microarray approaches. J. Biol. Chem. 276:43604–43610.
Levrero, M., De Laurenzi, V., Costanzo, A., Gong, J., Wang, J. Y., and Melino, G. 2000. The p53/p63/p73 family of transcription factors: Overlapping and distinct functions. J. Cell Sci. 113:1661–1670.
Lohrum, M. A. and Vousden, K. H. 2000. Regulation and function of the p53-related proteins: Same family, different rules. Trends Cell Biol. 10:197–202.
Pozniak, C. D., Radinovic, S., Yang, A., McKeon, F., Kaplan, D. R., and Miller, F. D. 2000. An anti-apoptotic role for the p53 family member, p73, during developmental neuron death. Science. 289:304–306.
Schreiber, S. S., Sakhi, S., Dugich-Djordjevic, M. M., and Nichols, N. R. 1994. Tumor suppressor p53 induction and DNA damage in hippocampal granule cells after adrenalectomy. Exp. Neurol. 130:368–376.
Kitamura, Y., Shimohama, S., Kamoshima, W., Matsuoka, Y., Nomura, Y., and Taniguchi, T. 1997. Changes of p53 in the brains of patients with Alzheimer's disease. Biochem. Biophys. Res. Commun. 232:418–421.
Kohji, T., Hayashi, M., Shioda, K., Minagawa, M., Morimatsu, Y., Tamagawa, K., and Oda, M. 1998. Cerebellar neurodegeneration in human hereditary DNA repair disorders. Neurosci. Lett. 243:133–136.
Li, Y., Chopp, M., Zhang, Z. G., Zaloga, C., Niewenhuis, L., and Gautam, S. 1994. p53-immunoreactive protein and p53 mRNA expression after transient middle cerebral artery occlusion in rats. Stroke. 25:849–855; discussion 855–856.
Tomasevic, G., Kamme, F., Stubberod, P., Wieloch, M., and Wieloch, T. 1999. The tumor suppressor p53 and its response gene p21WAF1/Cip1 are not markers of neuronal death following transient global cerebral ischemia. NeuroScience. 90:781–792.
Joo, C. K., Choi, J. S., Ko, H. W., Park, K. Y., Sohn, S., Chun, M. H., Oh, Y. J., and Gwag, B. J. 1999. Necrosis and apoptosis after retinal ischemia: involvement of NMDA-mediated excito-toxicity and p53. Invest. Ophthalmol. Vis. Sci. 40:713–720.
Manev, H., Kharlamov, A., and Armstrong, D. M. 1994. Photochemical brain injury in rats triggers DNA fragmentation, p53 and HSP72. Neuroreport. 5:2661–2664.
Hughes, P. E., Alexi, T., Yoshida, T., Schreiber, S. S., and Knusel, B. 1996. Excitotoxic lesion of rat brain with quinolinic acid induces expression of p53 messenger RNA and protein and p53-inducible genes Bax and Gadd-45 in brain areas showing DNA fragmentation. NeuroScience. 74:1143–1160.
Kaya, S. S., Mahmood,, A., Li,, Y., Yavuz, E., Goksel, M., and Chopp, M. 1999. Apoptosis and expression of p53 response proteins and cyclin D1 after cortical impact in rat brain. Brain Res. 818:23–33.
Blum, D., Wu, Y., Nissou, M. F., Arnaud, S., Alim Louis, B., and Verna, J. M. 1997. p53 and Bax activation in 6-hydroxy-dopamine-induced apoptosis in PC12 cells. Brain Res. 751:139–142.
Schauwecker, P. E. and Steward, O. 1997. Genetic determinants of susceptibility to excitotoxic cell death: Implications for gene targeting approaches. Proc. Natl. Acad. Sci. U.S.A. 94: 4103–4108.
Xiang, H., Hochman, D. W., Saya, H., Fujiwara, T., Schwartzkroin, P. A., and Morrison, R. S. 1996. Evidence for p53-mediated modulation of neuronal viability. J. Neurosci. 16:6753–6765.
Sadoul, R., Quiquerez, A. L., Martinou, I., Fernandez, P. A., and Martinou, J. C. 1996. p53 protein in sympathetic neurons: Cytoplasmic localization and no apparent function in apoptosis. J. Neurosci. Res. 43:594–601.
Davies, A. M. and Rosenthal, A. 1994. Neurons from mouse embryos with a null mutation in the tumour suppressor gene p53 undergo normal cell death in the absence of neurotrophins. Neurosci. Lett. 182:112–114.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Morrison, R.S., Kinoshita, Y., Johnson, M.D. et al. p53-Dependent Cell Death Signaling in Neurons. Neurochem Res 28, 15–27 (2003). https://doi.org/10.1023/A:1021687810103
Issue Date:
DOI: https://doi.org/10.1023/A:1021687810103